期刊
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32
卷 32, 期 -, 页码 189-225出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-immunol-032713-120136
关键词
adaptive immunity; adoptive immunotherapy; gene transfer; chimeric antigen receptor
类别
资金
- NATIONAL CANCER INSTITUTE [K08CA166039, R01CA120409] Funding Source: NIH RePORTER
- NCI NIH HHS [K08 CA166039, R01 CA120409] Funding Source: Medline
Adoptive immunotherapy, or the infusion of lymphocytes, is a promising approach for the treatment of cancer and certain chronic viral infections. The application of the principles of synthetic biology to enhance T cell function has resulted in substantial increases in clinical efficacy. The primary challenge to the field is to identify tumor-specific targets to avoid off-tumor, on-target toxicity. Given recent advances in efficacy in numerous pilot trials, the next steps in clinical development will require multicenter trials to establish adoptive immunotherapy as a mainstream technology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据